BRIEF published on 09/05/2024 at 08:05, 1 year 9 months ago Cairn Homes Plc : Transaction sur actions propres Rachat D'actions Euronext Dublin Rachat Bourse De Londres Courtiers En Valeurs Mobilières Goodbody
PRESS RELEASE published on 09/05/2024 at 08:00, 1 year 9 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchased 144,119 ordinary shares, part of their buyback program. Highest price paid: €1.9580, Lowest: €1.9300, VWAP: €1.9457 Cairn Homes Plc Repurchase Buyback Program Share Prices VWAP
BRIEF published on 09/04/2024 at 08:05, 1 year 9 months ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
BRIEF published on 09/04/2024 at 08:05, 1 year 9 months ago Cairn Homes Plc : Transaction sur actions propres Rachat D'actions Cairn Homes Plc Euronext Dublin Actions Ordinaires Bourse De Londres
BRIEF published on 09/04/2024 at 08:05, 1 year 9 months ago Cairn Homes Reports Record Performance for H1 2024 Financial Results Revenue Growth Sustainability Operating Profit Future Outlook
BRIEF published on 09/04/2024 at 08:05, 1 year 9 months ago Cairn Homes annonce une performance record pour le premier semestre 2024 Résultats Financiers Durabilité Croissance Des Revenus Perspectives D'avenir Résultat D'exploitation
PRESS RELEASE published on 09/04/2024 at 08:00, 1 year 9 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 147,976 of its ordinary shares on Euronext Dublin and London Stock Exchange through Goodbody Stockbrokers UC. Shares will be cancelled as part of buyback program London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 09/04/2024 at 08:00, 1 year 9 months ago Cairn Homes Plc: Results for the Six Months Ended 30 June 2024 Cairn Homes plc announces record H1 performance with 67% revenue increase and strategic growth plans. Financial and operational highlights shared Revenue Increase Cairn Homes Plc Growth Plans Financial Highlights Record Performance
BRIEF published on 09/02/2024 at 18:30, 1 year 9 months ago Cairn Homes Plc Announces Total Voting Rights Ordinary Shares Total Voting Rights Cairn Homes Transparency Regulations 636,642,951
BRIEF published on 09/02/2024 at 18:30, 1 year 9 months ago Cairn Homes Plc annonce le nombre total de droits de vote Actions Ordinaires Règlement Sur La Transparence Maisons Cairn Total Des Droits De Vote 636 642 951
Published on 06/26/2026 at 14:05, 56 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 1 minute ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 1 minute ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 16 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 01:40, 13 hours 21 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/26/2026 at 14:00, 1 hour ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 1 hour 1 minute ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 1 hour 28 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 1 hour 30 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 1 hour 30 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 8 hours 1 minute ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 1 minute ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
